Meredith Pols
Primary Care · Huntsville, ALNPI 1235594953
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novo Nordisk at 32.4% of the total.
Across 176 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$957
- AstraZeneca$434
- Exact Sciences$216
- AbbVie$148
- Sanofi-aventis U.S. LLC$146
- Phathom Pharmaceuticals, Inc.$143
- plus $911 from 15 others
What the payments were for
- Food & beverage$2,956100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 73 | $957 |
| AstraZeneca | 22 | $434 |
| Exact Sciences | 9 | $216 |
| AbbVie | 8 | $148 |
| Sanofi-aventis U.S. LLC | 7 | $146 |
| Phathom Pharmaceuticals, Inc. | 12 | $143 |
| Bayer | 7 | $129 |
| Amgen | 6 | $117 |
| Astellas Pharma US Inc | 5 | $113 |
| Lilly USA, LLC | 5 | $111 |
| Abbott | 4 | $90 |
| Antares Pharma, Inc. | 3 | $63 |
| Dexcom, Inc. | 2 | $57 |
| GSK | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Boehringer Ingelheim | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Merck | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $14 |
How this compares
$2,956 in reported general payments places this provider in the 75th percentile of 159 primary care providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 29 | $44,184 |
| JardianceEmpagliflozin | 31 | $39,401 |
| EliquisApixaban | 16 | $27,173 |
| FarxigaDapagliflozin Propanediol | 12 | $12,893 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $10,332 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 32 | $3,349 |
| Rosuvastatin Calcium | 118 | $1,958 |
| Telmisartan | 60 | $1,791 |
| Omeprazole | 85 | $1,527 |
| Fluticasone Propionate | 116 | $1,512 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 67 | $1,487 |
| Telmisartan-HydrochlorothiazidTelmisartan/Hydrochlorothiazid | 12 | $1,404 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 24 | $1,322 |
| Amlodipine Besylate | 207 | $1,101 |
| Esomeprazole Magnesium | 26 | $1,083 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $957 | $44,18429 claims |
| Boehringer IngelheimJardiance | $31 | $39,40131 claims |
| AstraZenecaFarxiga | $434 | $12,89312 claims |
| GSKTrelegy Ellipta | $55 | $10,33214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 159 primary care providers in Alabama.
Other primary care in Huntsville
- Cleo ValdezHuntsville$14K
- Christine WoodHuntsville$5K
- Allison BrownHuntsville$4K
- Emory ColemanHuntsville$3K
- Alyson JusticeHuntsville$2K
- Emily KomaraHuntsville$2K
- Johnnie AmadiHuntsville$2K
- Keith MatthewsOpelika$20K
- Troy HendersonFultondale$18K
- April TateDothan$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.